Defeating Afghanistan's drug fix
Forced eradication and legalization are attractive options that are bound to backfire.
By Nick Grono and Joanna Nathanfrom the May 31, 2007 edition
Page 1 of 2
Brussels and Kabul, afghanistan - It's spring in Afghanistan, and poppy farmers are smiling. Heavy rains this winter portend a bumper opium harvest. Afghanistan already produces nine times the total opium output of the rest of the world combined, and while last year's crop was the largest the country has ever produced, this year's crop is likely to be even bigger.
The exploding drug trade is both a symptom and a source of instability and corruption. It is not just a case of evil drug traffickers taking advantage of a good but ineffective government to facilitate terrorism and insurgency – as frequently portrayed. The traffickers and their agents are all too often corrupt government officials themselves, who forge alliances of convenience with insurgent groups, including the Taliban, to protect their businesses and distribution routes.
There are no quick solutions to tackling this growing plague. But that doesn't mean policymakers can't make progress in undercutting the drug trade. The challenge will be to keep them focused on smart courses of action that yield long-term results – and away from superficially "easy" policies that end up backfiring.
In fact, when it comes to controlling drug production in Afghanistan, it is much easier to say what won't work than what will. For example, large-scale forced eradication (for example, by aerial spraying of crops, as advocated by some US policymakers), will not work. It might cause a temporary dip in production – but it will also force prices higher, thereby increasing incentives to produce more the following year. Indeed, it will probably benefit the drug traffickers who have a stockpile to sell at inflated prices, while farmers whose livelihoods are destroyed could be driven into the arms of insurgent groups.
Another superficially attractive solution that has been getting increasing attention is that of legalizing, or "licensing," the production of opium for medicinal purposes.
But this option would solve a problem that does not exist and fail to address several that do.
The International Narcotics Control Board categorically asserts there is already an oversupply of opiates for medical purposes. But even if there was an unmet demand, Afghanistan is perhaps the world's least suitable place to meet it. Countries such as Turkey, India, and Australia are already licensed to supply opiate raw materials. These countries, with their effective law enforcement and an absence of widespread armed conflict, are much better placed to meet any such demand than conflict-ridden Afghanistan.









CSMonitor.com
The Christian Science Monitor